FrontPoint Insider-Trader Ordered To Pay $38.2 Million

Nov 18 2011 | 2:32am ET

The former FrontPoint Partners healthcare hedge fund manager who admitted to insider-trading was ordered to pay almost $40 million in disgorgement and fines.

Joseph Skowron, who pleaded guilty to trading on confidential information in August, was hit with $38.2 million in disgorgement, prejudgment interest and civil penalties by U.S. District Judge Deborah Batts on Wednesday. The man who passed Skowron his information, French doctor Yves Benhamou, was ordered to pay more than $60,000.

Much of Skowron's liability may be covered by Morgan Stanley, the former owner of FrontPoint. Morgan Stanley agreed to indemnify FrontPoint when the latter spun off from the bank earlier this year.

But Morgan Stanley is trying to get that money right back from Skowron, who admitted he used information received from Benhamou about a Human Genome Sciences drug trial to avoid some $30 million in losses. Morgan Stanley is seeking $37.4 million in restitution from Skowron, which it accuses of causing "very substantial damages," including its $116 million write-down of its FrontPoint investment after the allegations against Skowron became public late last year.

Morgan Stanley settled the Securities and Exchange Commission's allegations against FrontPoint for more than $33 million, and said that FrontPoint paid Skowron at least $32 million during the four years he was breaking the law.

Also seeking restitution is another hedge fund brought low by insider trading, Galleon Group. Raj Rajaratnam's defunct outfit claims it lost more than $1.5 million on its Human Genome investments due to Skowron's actions. Deutsche Bank claims similar losses of $2.4 million.

Skowron is to be sentenced today. His plea agreement calls for five years in prison.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Often seen as a passion project, or part of a philanthropic venture, rare and fine stringed instruments offer an exciting option to diversify one’s investment portfolio while providing an opportunity for an exceptional long-term investment.